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Abstract
Background: Systems science methods such as dynamic simulation modelling are well suited to address questions
about public health policy as they consider the complexity, context and dynamic nature of system-wide behaviours.
Advances in technology have led to increased accessibility and interest in systems methods to address complex
health policy issues. However, the involvement of policy decision makers in health-related simulation model
development has been lacking. Where end-users have been included, there has been limited examination of their
experience of the participatory modelling process and their views about the utility of the findings. This paper
reports the experience of end-user decision makers, including senior public health policy makers and health service
providers, who participated in three participatory simulation modelling for health policy case studies (alcohol
related harm, childhood obesity prevention, diabetes in pregnancy), and their perceptions of the value and efficacy
of this method in an applied health sector context.
Methods: Semi-structured interviews were conducted with end-user participants from three participatory
simulation modelling case studies in Australian real-world policy settings. Interviewees were employees of
government agencies with jurisdiction over policy and program decisions and were purposively selected to include
perspectives at different stages of model development.
Results: The ‘co-production’ aspect of the participatory approach was highly valued. It was reported as an essential
component of building understanding of the modelling process, and thus trust in the model and its outputs as a
decision-support tool. The unique benefits of simulation modelling included its capacity to explore interactions of
risk factors and combined interventions, and the impact of scaling up interventions. Participants also valued
simulating new interventions prior to implementation in the real world, and the comprehensive mapping of
evidence and its gaps to prioritise future research. The participatory aspect of simulation modelling was time and
resource intensive and therefore most suited to high priority complex topics with contested options for
intervening.
Conclusion: These findings highlight the value of a participatory approach to dynamic simulation modelling to
support its utility in applied health policy settings.
Keywords: Dynamic simulation modelling, Participatory modelling, Public health, Prevention policy, Diabetes in
pregnancy, Gestational diabetes, Alcohol, Childhood obesity, Decision support, Multimethod modelling, Hybrid
modelling, Knowledge mobilisation
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Background
Evidence informed decisions are essential to ensure that
health policies provide cost effective and high-quality
programs and services. However, barriers to the use of
evidence to inform decision making remain [1]. Policy
and program decision making processes are frequently
non-linear and iterative. They are influenced by a range
of factors, that compete with research evidence, such as
the political environment, budget and resource con-
straints, and public perceptions of the value of policy op-
tions being considered, [1–6]. Evidence provided to
policy makers needs to be in a form that is useful and
relevant in this context [4, 7, 8]. Policy makers require
synthesised and contextualised evidence that establishes
the need for a policy response, compares and prioritises
policy options, and demonstrates cost-effectiveness of
interventions [4, 9].
Research evidence for the prevention of chronic dis-
ease often points to a large range of contributing risk
factors, including broader social determinants of health
[10, 11]. Without tools to make sense of this complex
array of evidence it is difficult to understand the dy-
namic interactions of risk factors and interventions [12],
potentially leading to the adoption of approaches that
may seem intuitive but fail to deliver reductions in dis-
ease burden at the population level or lead to unin-
tended consequences [12, 13].
Systems science methods are well suited to public
health and disease prevention questions because the ap-
proach takes into account the complexity, context, dy-
namic nature, and system-wide behaviour associated
with public health issues [14]. Dynamic simulation
models recreate complex systems and human behaviours
as computer simulations. They can be used to synthesise
evidence, answer hypothetical questions about the po-
tential outcomes of policy and intervention options, and
inform decision making [13, 15].
Incorporating a participatory process into the develop-
ment of dynamic simulation models can facilitate the ex-
ploration of how multiple environmental factors,
individual risk profiles and interventions interact [16,
17]. It can be used to enhance knowledge about the
focus issue from the perspective of different disciplines,
explore conflicting views, test potential solutions to
complex issues and even to develop a shared language
about the issue which can support ongoing communica-
tion [18–21]. The participatory model development
process involves an in-depth, interdisciplinary deliber-
ation and co-production process to initially map the
causal pathways for the focus issue, and the mechanisms
by which interventions have an effect on outcomes [19].
A range of evidence is synthesised, including empirical
evidence, expert and practice based knowledge, and the-
ory, to develop, quantify and test a simulation model of
the issue [13, 18, 19, 22, 23]. The resulting dynamic
simulation model can be used as a decision support tool
to explore complex problems such as the prevention of
chronic disease and simulate proposed policy and prac-
tice scenarios [13, 23].
Advances in technology have led to increased adoption
of tools and methods aimed at integrating diverse evi-
dence sources to inform decision making [13, 17]. How-
ever, rigorous assessment of the value and utility of
these methods and tools is required if their adoption to
support evidence informed policy and planning in the
health sector is to be achieved. The uptake of dynamic
simulation modelling in health has lagged behind other
sectors, such as the environmental sciences and business
industry [24], and it has been argued that this has, at
least in part, been due to limited engagement with stake-
holders and involvement of end-users in health-related
simulation model development [13, 21, 24, 25]. This has
also impacted on the implementation of model findings
[24, 26] and led to a reluctance among “non-researchers”
to use models as decision support tools [21, 24]. Where
policy makers have been included in the simulation
modelling process there has been limited examination of
their experience; e.g. perspectives on the utility of the
model, learning relating to the development and use of
the model, or commitment to implement the model
findings [13, 27, 28].
This paper reports on the experience of end-user deci-
sion makers, including senior policy makers and health
service providers, who participated in three participatory
simulation modelling case studies in Australian health
policy settings. We report on their perceptions of the
value and efficacy of this method as a tool for evidence
synthesis and decision support in applied health sector
policy and service planning contexts.
Methods
Context
The Australian Prevention Partnership Centre (http://
preventioncentre.org.au/), in collaboration with jurisdic-
tional governments have pioneered the co-production of
sophisticated, multiscale dynamic simulation models to
support health policy and practice decisions [29–33]. In
developing these models, researchers partnered with
health departments, clinicians and regional planners in
collaboration with a multidisciplinary group of stake-
holders using a participatory process [32, 33]. This re-
search is based on three of these case studies described
briefly below (Table 1). The case studies and participa-
tory processes are described more fully elsewhere [34].
Procedure
The evaluation of the participatory modelling process was
informed by the Challenge and Reconstruct Learning
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(CHARL) Framework proposed by Smajgl and Ward [35].
The CHaRL framework involves assessing formalised and
facilitated learning among decision makers and decision
influencers at varied policy levels in deliberative processes.
The key component of the CHaRL framework is the
change in perception or belief about assumed causality
within the system. The change in perceptions or beliefs
can be measured using individual value and attitude/belief
orientations recorded by participants before and after the
modelling process [35].
The three modelling case studies were chosen to allow
for data to be collected at all stages of the participatory
process. The model development process had been fina-
lised in two of the case studies, and data were also col-
lected on the use of models to inform decision making.
Data collections are described below.
For data triangulation, key informant interviews and
participant observation during workshops (field notes
kept by lead author LF) were used to collect information
across the three case studies as outlined below.
1. Pre-workshop interviews (Diabetes in Pregnancy
project n = 5)
2. Post workshop interviews (all case studies n = 7)
3. Workshop observations (all case studies, total
workshops n = 9)
Qualitative analysis was conducted for the transcripts
from the semi-structured interviews, and the observation
field notes. The data collection and analysis methods are
described in detail below.
Participants and sampling
Purposive sampling was used for each case study to re-
cruit participants with a range of expertise, including
providing or planning health services, undertaking re-
search or developing policy for the issue in focus.
Pre-process interviews in the DIP case study occurred
with six participants that included senior clinical and
public health policy decision makers.
Sampling for the post workshop interviews (n = 7) en-
sured representation across the three case studies to in-
clude perspectives from case studies with models at
different stages of development and project roles, (e.g.
facilitator or participant), or policy making roles, (e.g.
clinical, policy, or public health executive). Some inter-
viewees had participated in more than one case study.
Focus for selection in the post-process interviews was
on the setting where policy change decisions would
occur i.e. interviews were with participants who were
employed within government agencies with jurisdiction
over the relevant policy decisions. Recruitment of inter-
viewees continued until saturation was reached for the
main themes and categories.
Data collection
Participant experiences and perspectives across all three
case studies were collected in semi-structured interviews
with key informants focusing on their personal response to
the participatory modelling process and perceptions of the:
○ value of simulation modelling as policy decision
support tool
Table 1 Description of dynamic simulation modelling case studies and context
Topic area Type of model Model
development
period




Agent based model 2015–2016 Alcohol misuse is an important public health issue
for which there are complex causal mechanisms
and contested intervention options. This model
was developed to inform jurisdictional government
strategies for reducing alcohol-related harms.
The model represents the heterogeneity of alcohol
use across the population, how the dynamics of
drinking behaviours vary across the life course, the
harms, both short and long term, that arise from
alcohol use, and the differential effects of





System dynamics model 2016 In 2015, an Australian State Premier set an
ambitious target to reduce childhood overweight
and obesity in children by 5 % over 10 years. It was
predicted that additional strategies, or
combinations of strategies, would be required to
achieve the Premier’s target. Decision makers were
presented with the challenge of determining
where best to focus resources and efforts.
The model explores the complex issue of child
overweight and obesity, incorporates existing
programs and tests the likely impacts of a range of
policies and programs. It forecasts the combination










2016–2017 . Diabetes in pregnancy is increasing in Australia
and internationally and exploration of new
strategies to prevent and manage the condition is
needed. The model considers the short, and long-
term implications of the increasing prevalence of
both DIP and associated risk factors.
The model focuses on the development of
Diabetes in Pregnancy (DIP) from the perspective
of the individual. Prevention interventions were
prioritised in the model as delays in the
development of diabetes will potentially result in
reduction in the longer-term burden of disease
and costs to the health system. However, the
model can also explore clinical interventions.
Health service utilisation has been captured in the
model enabling it to explore the resource impact
of model of care scenarios.
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○ strengths and limitations of the method and
intention to use simulation modelling in the future
○ perceived enablers and barriers to the use of
simulation modelling
Interviews were conducted face to face where possible
(n = 5), however telephone and web conferencing inter-
views (n = 8) were also used to allow interviews with par-
ticipants in distant locations. Interviews across formats
were of comparable length (ranging from 30 to 60min)
and depth of exploration of the issues discussed. Inter-
views were conducted by the lead author and a research
officer (EO - two pre-workshop interviews, see acknowl-
edgements). Indicative questions for pre- and post- inter-
views are presented in Additional file 1. Field notes were
based on observations of the participatory workshops and
debriefing discussions between the authors and research
officers (EO, NR and CW, see acknowledgements).
Data coding and analysis
Interviews were audio recorded and transcribed using a
professional transcription company, checked for quality
and de-identified. The transcriptions were coded and
analysed by LF. The analysis was guided by grounded
theory principles [36, 37]. An iterative process of de-
scriptive coding and analytical memos was used to de-
velop themes and conceptual categories, explore their
inter-relationships, and to triangulate insights from the
interview and field note data. The progressive analysis
was iteratively reviewed by JA and LR and further re-
vised as new data was incorporated. Analytic memos
written by LF were also shared with JA and LR to facili-
tate the analysis review process.
Results
Table 2 provides an indication of the data analysed for
each results section.
Pre-modelling perceptions of evidence use in decision
making
Prior to the commencement of the participatory model-
ling process, respondents consistently emphasised the
importance of evidence-informed decision making how-
ever, they identified challenges relating to the availability,
applicability, persuasiveness, timeliness and accessibility
of evidence to inform decision making.
Lack of evidence was described as the “biggest chal-
lenge” in circumstances where no policy relevant evi-
dence existed, or the available evidence was not
sufficiently robust to inform health policy or service de-
cisions. In situations where rigorous studies like rando-
mised controlled trials were not likely to be conducted
due to ethical, practical, or funding constraints, there
was a clear view that an ongoing lack of evidence was
unlikely to be resolved using traditional methods of re-
search. Further, when evidence was available, it was not
necessarily applicable to local health service or popula-
tion context, making it difficult to use for local policy
decisions.
Evidence was reported to be only one of many com-
peting factors involved in decision making and respon-
dents described other factors as more powerful decision
influencers. Evidence needed to be convincing to com-
pete with these other influences, including the input of
advocacy groups, incentives and restrictions built into
funding models and internal (organisational) and exter-
nal (political and community) competition for resources.
It was also reported that the use of evidence in policy
decision making continued to be limited by poor accessi-
bility. Thus, research needed to be communicated in
more accessible ways to policy makers who vary in their
level of expertise in interpreting and applying research
findings. Policy makers and program planners often
prioritised government reports and statistics, and
non-government organisation reports to inform deci-
sions as they used more accessible language and were
free to access. Some policy makers were unable to access
journal articles behind a “pay wall”. It was widely re-
ported that there was little time in policy settings to ex-
plore evidence in detail or to conduct research. In this
context, respondents consistently identified that there
was significant room for improvement in the way evi-
dence was translated and used to inform policy and
practice decisions. As a result, respondents were
Table 2 Overview of data analysed for each results section
Results section Analysis based on:
Pre-modelling interviews Post-modelling interviews
DIP DIP Alcohol Childhood Obesity
Pre-modelling perceptions of evidence use in decision making X
Experiences of participatory modelling X X X
Learning through participation X X X
Experience of using dynamic simulation modelling to inform decision making X X
DIP - Dynamic simulation modelling to inform the prevention and management of diabetes in pregnancy
Alcohol - Dynamic simulation modelling to inform reductions of alcohol related harms
Childhood Obesity - Dynamic simulation modelling to inform how best to reach the Premiers target for reducing childhood overweight and obesity
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motivated to explore new methods, such as participatory
dynamic simulation modelling, to see how they could
improve and increase the use of evidence in their applied
settings.
Experiences of the participatory simulation modelling
process
As identified in Table 2, this section is based on
post-modelling interviews across the Diabetes in Preg-
nancy, Alcohol and Childhood overweight and obesity
case studies.
Motivations for participating
Due to the significant time investment involved in par-
ticipatory dynamic simulation model development, the
opportunity costs and likely outcomes from the model-
ling projects were significant factors in policy makers’
decision to participate in the process. Targeted and tai-
lored engagement, facilitated by a trusted domain expert,
with key participants in the planning phase of the pro-
ject was important to justify the benefits of participating
and ensure that from the policy makers’ perspective, the
topic was high priority, of professional interest, complex
and had contested options for intervening. Across the
modelling case studies, many interviewees reported that
they explicitly considered the opportunity cost of partici-
pating in the dynamic simulation modelling project be-
fore deciding to become involved. They went through a
process of weighing up whether the likely outcomes
from the modelling projects would be worthwhile given
the significant time commitment required.
Commonly reported reasons for agreeing to participate
included: the person’s professional involvement and ex-
pertise in the topic being modelled, the trusted relation-
ship with either the modelling team or the lead domain
expert involved in the project, curiosity about dynamic
simulation modelling and participatory methods, and as-
pirations to improve the use of evidence in decision
making. These are explored further below. A few partici-
pants were directed to participate by their organisation.
The choice of focus topic to be modelled was a key
criterion for agreeing to join the participatory dynamic
simulation modelling project. The topic needed to be an
important local priority of current professional and or
organisational concern with complex causal risk factors
and need for policy or programme response. In order to
justify the commitment to participate the topic needed
to be complex with different perspectives of which
causal factors and exposures were important, different
intervention options to decide between, contested views
about what works and what doesn’t, and where the com-
bined impact of interventions was unknown.
Trust in and familiarity with the project team were
commonly identified as important factors influencing
the decision to participate. Most interviewees embarked
on the project with little or no experience of dynamic
simulation modelling, however they had trust in the
modelling team or domain expert who initially
approached them, and this facilitated their decision to
participate.
“It's having known [facilitator] for a long time through
the [work area], and our work with the [topic X].
[Facilitator] knowing that part of my research was
based about [topic X] disease, and various other
things I've been looking at.” (Senior clinician)
An interest in learning new methods to facilitate evi-
dence informed decisions in public health was com-
monly identified as a reason to participate in the case
studies.
“I was interested in processes for better being able to
inform and educate the policy making process”
(Public health executive)
“it’s an incredibly useful policy tool if it's done
appropriately with the right people asking the right
questions. It's a very powerful tool.” (Public health
executive)
Goals for participating in the case studies included
learning about the process of developing a simulation
model and how it can be used to inform decision mak-
ing. The participatory approach was highly valued by
most interviewees as it provided an opportunity to com-
bine their expertise with the expertise of the modelling
team to produce an innovative decision support tool.
Engaging in the participatory activities
Workshop participants engaged in a range of large and
small group activities to collaboratively develop a con-
ceptual map of the problem, prioritise and map the im-
pact of interventions to model architecture and identify
data and evidence to incorporate into (or parameterise)
the models. These activities have been described in detail
elsewhere [34].
Collaboration and co-production
Collaboration and co-production were identified by par-
ticipants in these case studies as the unique and highly
valued aspect of the participatory dynamic simulation
model development. The participatory approach facili-
tated the contribution and synthesis of a significant
knowledge base and was critical to eliciting and negoti-
ating priority causal factors, exposures and interventions
to be represented in the model. The process of contrib-
uting expertise and then explicitly seeing how it was
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used in the model were important factors in facilitating
engagement and a sense of ownership in the model.
“The session with lots of string and sticky notes and
things on the board, it looked a mess and going away
thinking, “How are they going to use all that?” But I
actually was surprised, pleasantly surprised, at how
that was actually used to inform the development of
the model, and it really was.” (Senior clinician)
The contribution of considerable knowledge and di-
verse expertise of participants was consistently identified
as important. Many respondents commented that they
were surprised at the willingness of participants to con-
tribute their experience, ideas and knowledge to educate
the modelling team about the issue and guide the model
development.
“I think the participatory approach, you're having
people in the room that have accumulated knowledge,
expertise in the area over quite a number of years,
actually brings a lot of knowledge into that room, and
it's not possible for one or three or five people to do
the literature searches and understand all the
information” (Senior clinician)
Respondents also noted that people “put their egos
aside” during the workshops as the interdisciplinary and
co-production approach meant that participants were
learning from each other. The content expert partici-
pants learned about dynamic simulation modelling and
the modellers learned about the priority public health
issue being modelled.
While being time consuming and personally challen-
ging for some respondents to engage in; the interactive
activities and group discussions were viewed as critical
to eliciting and negotiating priority causal factors, expo-
sures and interventions to be represented in the model.
Many respondents noted that the same outcome could
not be achieved through one on one discussions as the
inclusion of a diverse range of participant perspectives
was important to guide the model development.
“By having everybody in the same room, you got to
really be able to relate to everybody's little piece of the
puzzle. I think if you had just done that with
individuals, you wouldn't have got the model that
you've developed.” (Senior clinician)
The lack of consumer involvement in the modelling
case studies described in this paper was identified as a
gap in representation. However, respondents also noted
that finding consumer representatives and strategies to
realise the benefits of consumer input can be challenging
in some circumstances e.g. when the discussion is fo-
cused on highly specialised biological causal mechanisms
of disease development and progression.
Some respondents reported that they initially per-
ceived the workshop activities to support active partici-
pation as less rigorous or evidence-based than they had
expected. For example, that some participants were rely-
ing on their opinion rather than evidence, were advocat-
ing for causes or had a priori preferences for particular
actions and thus a potentially biased view of the evi-
dence. A couple of participants noted that they observed
differential engagement by other participants with the
activities and “people not taking it as seriously as per-
haps they should have”. However, most of these respon-
dents also noted that as the model development process
progressed they were reassured by the use of good data
and evidence to inform the model and to test hypotheses
that came from expert opinion.
“I was a bit sceptical of that process, and in terms of
input given that it's meant to be evidence-based in-
puts through that conceptual mapping of the bits of
paper and string, and plaster, ... I expected it to be
more rigorous, but I learned by doing it, that really it
was more about informing the modelling team in
terms of logic, structure and models, and then they
went away and found the evidence, if you like, to sup-
port the link of this, and of course all pathways, and
the association pathways.” (Public health executive)
Contributing expertise and then explicitly seeing how
it was used in the model were important workshop ac-
tivities. The process of unfurling the model by describing
the logic and architecture and relating it to discussions
at previous workshops was highly regarded by partici-
pants. The model was viewed as “the fruits of their
labour” and a sense of innovation and excitement was
expressed by many respondents.
Two key roles were identified as facilitating engage-
ment in these case studies. The first was having a
trusted domain expert for each project who was a
well-respected authority on the focus issue and played
a lead role in the project planning and workshop fa-
cilitation. The domain expert facilitated the ap-
proaches to key stakeholders, increasing the likelihood
of their agreement to participate, and was a known
colleague to promote engagement in the participatory
process. The second “translator” role was identified
by respondents who were more closely involved in fa-
cilitating workshops and working with participants.
This role involved both explaining the policy context,
e.g. current policy priorities and interventions, and
contextualising the data, e.g. explaining data collec-
tion methods, representativeness and limitations, for
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the modelling team and conversely translating the
model requirements and development process to the
workshop participants.
Having an embedded policy officer, who along with
the lead domain expert, played the role of translator
working within the modelling team ensured that the
model was policy relevant, well understood and used. A
key aspect of this was being able to run model scenarios
independently of the modelling team to provide timely
responses to policy questions (e.g. switching interven-
tions on and off and/or modifying parameters such as
reach and effectiveness and producing results).
Participant learning through group model building
Respondents reported that the participatory process
worked well in facilitating interactions and contributing
expertise. The process also provided an opportunity for
the expert participants to be exposed to multiple perspec-
tives and frameworks for viewing the problem but was not
identified as resulting in individual learning about the
focus issue. A commonly cited reason for this was the se-
lection of participants who were experts in the focus issue,
many of whom had dedicated their career to working on
it. They came to the process with a good understanding of
the different perspectives and complex causal relation-
ships e.g. costs, drivers, and evidence-based strategies.
“I think it gave people a broad picture and they
recognised where everybody's different areas fit. But
whether it actually changed how they link things
together, I don't know.” (Senior clinician)
However, all respondents reported that they learned
about the potential of dynamic simulation modelling to
support decision making and the process of developing
simulation models through the participatory process.
“What we learned is the potential value of developing
a simulation model. Talking to the others, everyone
was quite impressed by where it's got to, so the
exchange and knowledge between the different
discipline areas, I guess, was the most positive. ... I
don't think you've changed our views very much on
[topic X]. ” (Senior clinician)
Interviewees identified that the participatory modelling
process and model outputs allowed participants to de-
velop insights into the interrelationships between causal
factors and emergent behaviour of the system i.e. “If you
change your practice how does that impact on other
parts of the system”; explore the combined impact and
interaction between interventions; and explore new and
untested interventions in the model prior to them being
implemented in the real world. These important learning
outcomes and how they can be used to facilitate policy
conversations are discussed in more detail below.
“That's I think what the benefit of the model will be,
is that it can show to people if you change one thing
here, what's it going to change for everything else.”
(Senior clinician).
How dynamic simulation models facilitate the use of
evidence to inform decision making
The following analysis is primarily based on responses
regarding the two simulation models that were finalised
at the time of writing (Alcohol and Childhood obesity).
The exception to this is the discussion regarding the
identification of evidence gaps which includes responses
from all case studies.
Participatory approach and trust in the model as a decision
support tool
The participatory approach used in the model develop-
ment engaged respondents actively in the process and
increased their familiarity and trust in the model out-
puts. Respondents reported an increased sense of owner-
ship and interest with these models compared with
other modelling projects that had not used a participa-
tory approach.
“…there were times where I'm thinking, “Really? We
know all this stuff, and do we have to spend all this
time?” But you realise that that's the nature of it, that
if we didn't go through those processes there wouldn't
be the same trustworthiness, or people wouldn't trust
it as much, they'd be questioning it.” (Public health
executive)
Respondents valued that the model was transparent
about “what’s under the hood”. They noted that they
understood the logic of the model and the evidence used
to inform it and this increased their trust and willingness
to use the model to facilitate policy and program plan-
ning conversations.
Model outputs were described as involving a bit of
“science and magic” or “computer magic” that was en-
gaging and useful, however concern was expressed that
model outputs could be interpreted by people not in-
volved in the participatory process as reality rather than
as a decision support tool to compare alternative strat-
egies. Respondents emphasised their awareness of the
limitations of the models, the need to ensure that model
outputs were interpreted appropriately and for end-users
to be aware of the assumptions and limitations of the
evidence used in the models.
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Many respondents discussed the importance of ensur-
ing that the participant group included representatives
for the policy and intervention options being considered
in the models. For example, if regulatory interventions
were being considered then stakeholders who have regu-
latory oversight for the issue should be included in the
participatory process to increase trust and reduce the
risk of resistance from these stakeholders to using the
model to support decision making.
Using the model to synthesise and facilitate use of evidence
in policy conversations
The models were valued as communication tools. They
were viewed as giving credibility to the argument for
prevention interventions. The ability to manipulate pol-
icy levers to switch interventions on and off or to modify
the reach and effectiveness of interventions and then ob-
serve the impact on outcomes of interest were fre-
quently identified as providing an important evidence
base to support policy and planning conversations. For
example, model outputs were used to demonstrate the
impact of current programs and reinforce with local ser-
vice providers the importance of maximising reach and
effectiveness of their current programs and to inform
planning decisions by forecasting the impact of local in-
terventions if scaled up to the population level.
“Well, it's a neat graphical tool that assists the
presentation of data on effectiveness of programmes.
It's quite neat the way you can say, “Well, if we do
programme X, this is the result we're going to achieve
on this variable” It’s nice to be able to present a
dynamic model like that. In that sense, people engage
with it.” (Public health executive)
Dynamic simulation modelling was viewed by most re-
spondents as offering unique benefits, including the ability
to investigate the impact of intervention combinations and
interactions on outcomes, forecasting delays in intervention
effects and therefore informing expectations for perform-
ance monitoring of program implementation and providing
a tool to test the potential impact of new ‘bold’ innovative
interventions before they were rolled out in the real world.
“I think it's the learning, and the benefits of the
modelling, and the things it can do that we can't do
from normal longitudinal studies or trials, qualitative
work, it is impossible to do what the model does, but
that's the point of benefit.”(Public health executive)
The ability to dynamically interact with the model to
develop insights into which programs needed to be en-
hanced, which gaps needed to be filled and which target
groups to focus on were identified as important benefits
derived from dynamic simulation modelling. This dy-
namic interaction facilitated policy discussions for local
health program planning and engagement with other
agencies. The model outputs were used to explore which
interventions with which target groups would yield big-
ger benefits in the long term.
Many respondents noted that the interaction with and
communication of model insights were areas requiring
further development. The development of communica-
tion tools, such as interactive user interface tools and
presentations that could be easily adapted to different
audiences, were viewed as critical to facilitate the use of
the models in policy and program discussions to inform
decision making.
Due to delays in model development, the intended
presentation of one of the models to a broader range of
stakeholders was unable to occur within the anticipated
project timeline. A small number of respondents identi-
fied this as an important missed opportunity from a
co-production and participatory research perspective
that undermined the application of the model findings
to policy decisions.
Model maturing process
The dynamic simulation models were commonly viewed
as tools that would mature over time. The maturing
process was described in terms of continuously refining
the inputs, assumptions and parameters used in the
model as new knowledge and evidence became available;
building on the model when new policy questions arose
and maturing the methods used to communicate model
outputs such as user interfaces and presentation of re-
sults. The allocation of sufficient time to familiarise par-
ticipants with the use of the model, train “super users”
and socialise the models with broader stakeholder
groups were identified as important elements to support
the communication of model outputs and increase their
use in decision making.
Identifying and prioritising gaps in the existing evi-
dence base was an important component of the model
maturation process. The interactive discussions regard-
ing the causal factors and impact of interventions for
each focus topic facilitated the identification, clarifica-
tion and prioritisation of gaps in current knowledge and
evidence and could be used to guide future research.
Discussion
The aim of this research was to explore the experience
of end-user decision makers who participated in partici-
patory simulation modelling projects and the perceived
value and efficacy of this method as an evidence synthe-
sis and decision support method in an applied health
sector context from their perspective. Overall, the par-
ticipatory approach used to develop the dynamic
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simulation models was valued by these participants, in-
cluding both senior clinical experts and public health ex-
ecutives, and was an essential process for building trust
in the model as a decision support tool. The collabora-
tive, co-production principles used to develop the simu-
lation models facilitated participant understanding of the
logic and evidence used in the models and increased
their sense of ownership and willingness to use the
models for decision making. The models were broadly
viewed as useful and convincing communication tools to
facilitate policy discussions. The unique benefits of the
models included the ability to explore the interaction of
risk factors and causal mechanisms; the interaction and
combination of public health interventions; the impact
of scaling up the reach and effectiveness of existing pro-
grams and the impact of new and untested interventions
in simulation before they were implemented in the real
world. The participatory process was time consuming,
changeable and resource intensive. Therefore, complex is-
sues with contested options for intervening were more
likely to be viewed as worthwhile for the significant time
investment required for participatory model development.
Motivations for participating
Participating in research activities, including participa-
tory modelling, requires significant time investment for
stakeholders and it is important to consider the factors
that motivate their participation when planning research
[38]. Studies focusing on stakeholder inclusion in health
research, have often been from the perspective of the re-
searchers. Factors such as the difficulty of finding stake-
holders with the right skills and knowledge who are
interested and available to participate or the difficulty of
dedicating time to stakeholder engagement in a context
where it isn’t measured and may not be valued [39, 40],
have been the focus rather than the perspective of the
stakeholders and their motivations for becoming in-
volved. The case studies reported here provide insight
into the motivations from the stakeholder perspective.
Targeted recruitment of stakeholders with a professional
involvement and expertise in the topic being modelled,
facilitated by a trusted relationship with either the mod-
elling team or a lead domain expert involved in the pro-
ject were found in these case studies to be important
and successful strategies to motivate policy makers to in-
vest their time.
Motivations for community groups to engage in par-
ticipatory modelling have been found to be highest when
the problem needs to be solved with some urgency and
existing approaches have already been tried and failed or
known to be unsuitable for the problem at hand [16]. In
the complex and contested context of the priority focus
issues for the case studies reported here, policy makers
and health service providers were motivated to engage
in dynamic simulation modelling as a new method for
evidence synthesis and exploring “what if” scenarios for
policy analysis, particularly with a familiar and trusted
team.
Collaboration and co-production were key elements
valued in the participatory approach
Relationships and collaborations are frequently identified
as critical factors in systems approaches [41, 42]. Partici-
patory dynamic modelling provides a structured process
to facilitate inter-disciplinary dialogues and co-production
methods involving a range of participants, including
end-user decision makers. Participatory modelling ap-
proaches aim to combine diverse perspectives to tackle
the social complexity of problems and recognise that dif-
ferent types of knowledge contribute alternative and valu-
able perspectives to the problem discourse [18, 21, 23, 43].
Participants in the case studies reported in this paper
viewed the participatory process as a valuable
co-production approach to understand the focus issue
from a system perspective, for example, enabling the con-
sideration of how decisions made in one part of the health
service, or indeed by other government departments,
could impact on programs and services in another. The
ability to combine the significant knowledge from multiple
experts to guide the model development as a decision sup-
port tool was viewed as a unique benefit of the participa-
tory process.
Participatory model development and validation has
been shown to increase confidence that the model results
were both valid and useful for the participants’ local con-
text [19, 27, 44, 45]. Decision maker involvement in model
development resulted in them being more likely to draw
on the model’s outputs to inform decisions about priority
interventions and policies [27, 43, 46]. The involvement of
key stakeholders and decision makers in these case studies
was identified as critical to developing trust in the use of
the model to support decision making. Participants also
noted the importance of ensuring that representatives of
important stakeholder groups, such as consumers and
relevant policy agencies, were included in model develop-
ment process.
The domain expert and translator roles were identified
in these case studies as important to facilitate engage-
ment in the participatory process and use of the model
to inform decision making. Similar roles have been iden-
tified in community based environmental modelling
contexts [16, 45] as playing an important role liaising be-
tween the modelling team and stakeholders. The key ele-
ments for the translator role include being a member of
the stakeholder community who can both identify with
the needs and articulate them within a group model
building session and has credibility in translating and
conveying insights from the modelling process [16]. In
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the health setting case studies reported here, it was im-
portant that the “translator” was embedded within the
stakeholder organisation and facilitated the acceptance
and use of the model to support policy discussions.
Thompson et al. (2010) described the beneficial relation-
ship between the translator and the modellers as the
translators driving the modellers to integrate the partici-
pants’ requests and insights into the model, and the
modellers driving the translators to introduce complex
science and dynamic interrelationships to the stake-
holders [45].
Participant learning
Simulation modelling aims to enhance knowledge of
participants from the perspective of different disciplines
and more thorough exploration of focus problems using
systems science [21, 38]. The evaluation framework used
to guide the design of this research focused on changes
in perceptions about the assumed causality pathways in
the system to assess participant learning [35]. Inter-
viewees reported that the participatory process provided
opportunity to be exposed to multiple perspectives,
interact and contribute expertise, however they did not
identify that they had learned about the causal pathways
for the focus issue. Participants in the case studies re-
ported here were long term experts in the focus issue,
many of whom had dedicated their career to working on
the issue, therefore they came to the process with a good
understanding of the different perspectives and complex
causal relationships and therefore may not have gained
new knowledge through the participatory process. How-
ever, this finding is consistent with Rouwette et al. who
found that participants in group model development
processes experienced difficulty identifying their learning
from these processes without specific prompting [19].
Participatory modelling processes can be characterised
as social learning exercises [27], and the shifts in percep-
tions and learning that result can play out differently at
the individual and group levels [47]. Participatory mod-
elling involves the sharing of knowledge through group
discussion, interactive activities and interactions with the
model [27, 47]. Recent participatory modelling research
in the environmental sciences has found measures of in-
dividual cognitive change to be informative, but unable
to reflect how the group evolves in their capacity to
make decisions informed by the model [47].
All respondents in these case studies reported that
they learned about the potential of dynamic simulation
modelling to explore complex interrelationships for the
focus issue and emergent behaviour of the system to
support decision making and the process of developing
simulation models through the participatory process.
This was identified as an important learning outcome
and is consistent with the key benefit of participatory
modelling that people learn how to model better, and
with better modelling comes better insights to improving
the system [16]. To increase the sophistication and ef-
fectiveness of participatory modelling facilitation
methods, better understanding about how different
stakeholder groups evolve the knowledge and skills to
work with decision support tools like simulation models
to plan policy and programs will be an important area of
future research.
Intentions to use dynamic simulation modelling to inform
decision making
Stakeholders are more likely to trust a model if they
have been involved in informing and grounding the un-
derstanding captured in the model, they understand it
and they feel ownership [18, 48, 49]. The participatory
approach used in these case studies engaged policy deci-
sion makers actively in the model development process
which fostered their interest and trust in the model out-
puts. Making the model understandable and accessible
to stakeholders has been identified as an important
principle of participatory modelling [49] and was a key
benefit commonly identified across these case studies.
Participants understood the logic of the model and the
evidence used to inform it and this transparency in-
creased their trust and willingness to use the model to
facilitate policy and program planning conversations.
Ensuring stakeholder representation for the policy and
intervention options being considered in the models was
identified as a key consideration for project planning to
realise the benefits of the participatory process. Partici-
patory modelling has been shown to successfully facili-
tate productive problem solving across agency
boundaries by providing a neutral platform for discus-
sion and scenario testing to explore a broad range of op-
tions and solutions [16, 18, 48, 50]. The participatory
process can bring key stakeholders from different agen-
cies responsible for implementing policy and programs
together to explore and test “what if” policy scenarios
and explore which interventions represent the most ef-
fective leverage points in the local context and therefore
align and mobilise prevention efforts of community
stakeholders [51].
The finalised models in the case studies reported on
here are being used as credible, communication tools to
synthesise and facilitate use of evidence in policy conver-
sations regarding prevention interventions. The models
capture the complexity of real-world policy questions
and provide a dynamic analytic tool that can overcome
the limitations of traditional analysis methods [52, 53].
The ability to manipulate policy levers to determine im-
pact of interventions on health outcomes (including the
ability to test alternative reach, adoption, and effect sce-
narios) provided an important evidence base to support
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health policy and planning conversations and develop
realistic insights into the impact of enhancing or
expanding existing interventions and identify priority
gaps and areas of need.
The unique benefits offered by participatory dynamic
simulation modelling have previously been identified
from the perspective of modelling teams. For example,
helping stakeholders understand how multiple variables,
factors, and interventions interact, being able to test the
potential impact of programs and policies in the “safety”
of a virtual environment before they are implemented,
saving time, effort, costs and resources, guiding and
prioritising data collection and facilitating discussions
among stakeholders [49]. The importance of these bene-
fits to end-user decision makers was confirmed by these
case studies with participants identifying that the ability
to dynamically investigate the impact of intervention
combinations and interactions on outcomes, forecast de-
lays in intervention effects and test the potential impact
of new innovative interventions before they were rolled
out in the real world were valued and utilised in policy
and program decision making discussions. The benefits
of participatory dynamic simulation modelling methods
identified by the policy makers are summarised below.
These are benefits that dynamic modelling provides over
other forms of knowledge mobilisation [34, 23] from the
perspective of end-users of these models as decision
support tools.
Summary - unique benefits of participatory dynamic
simulation modelling identified by policy makers
 Increasing familiarity and trust in the model by use
of participatory, co-production methods.
 Synthesising diverse evidence in an interactive and
dynamic decision support tool that facilitates the
exploration of “what if ” scenarios and policy
options.
 Exploring the combination and interaction of
interventions to develop insights into which
interventions to enhance, which gaps to fill and
which target groups to focus on
 Exploring the impact of new and untested
interventions prior to implementation in real world
 Forecasting delays in intervention effects to guide
implementation monitoring
 Identifying and prioritising evidence gaps
Implementation challenges and future work
The co-production and participatory approaches to
model development were time consuming, unpredictable
and messy, making them more suitable for longer term
planning in the first instance. However, once the models
were developed they could be used for short-turnaround
policy advice. For these case studies, the intended pres-
entation of one of the finished models to a broader
range of stakeholders did not occur due to timing and
resource constraints. This was as an important missed
opportunity from a co-production and participatory re-
search perspective that undermined the application of
the model findings to policy decisions.
The refinement of communication tools, such as inter-
active user interface tools and presentations that could
be easily adapted to different audiences, will be critical
to facilitate the use of the models in policy and program
discussions to inform decision making.
Supporting good understanding of the model develop-
ment process, for example, how decisions are made re-
garding the methods used to represent causal
mechanisms dynamically, where to add complexity,
where to simplify the model and how to deal with and
communicate uncertainty in the models are important
ongoing challenges. These are the subject of future work
in this program of research on participatory modelling.
The dynamic simulation models are tools that mature
over time with the inputs, assumptions and parameters
being continuously refined and updated as new know-
ledge and evidence become available. The identification
and prioritisation of gaps in the existing evidence base
was facilitated by the interactive discussions regarding
the causal factors and impact of interventions for each
focus topic and used to guide future research priorities.
Key implementation strategies are summarised below.
The strategies cover practical aspects of the workshop
facilitation and important aspects of communication and
engagement with participants before, during and after
the model development workshops. It is important to
acknowledge that these strategies are not intended to be
prescriptive. Each modelling has project has unique re-
quirements, stakeholders and policy context, and there-
fore being flexible and responsive to project needs and
stakeholder feedback is critical.
Summary of implementation strategies for project phases
Key project roles
Domain expert – well-respected authority on the focus
issue who can play a lead role in the project planning
and workshop facilitation.
Translator – person who can contextualise the policy
environment and data for the modelling team and trans-
late the model requirements and development process
to the participants.
Expert participants – people with a range of expert-
ise, including providing or planning health services,
undertaking research or developing policy for the issue
in focus.
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Dynamic simulation modeller – person with computer
programming and data analysis expertise in developing
dynamic simulation models.
Super-user – person who learns to use the model
interface and apply it to explore policy scenarios
“in-house”. They are usually employed by the jurisdic-
tional health department in analytic roles.
Planning phase
1. Use a domain expert to facilitate engagement and
trust.
2. Engage a broad range of participants to provide
diverse and representative perspectives. Important
to include “domain expert”, “translator”, “clinical
experts”, “modeler”, “policymakers”, “super users”
3. Provide background briefing material about the
participatory process prior to the workshops to
enable participants to prepare and do “pre-thinking”
4. Increase motivation to participate by engaging with
key stakeholders from lead agencies in the planning
phase to ensure the focus topic is high priority and
of professional interest. Complex issues with
contested options for intervening are more likely to
be viewed as worthwhile for the significant time
investment required for participatory model
development.
5. Wherever possible, book workshops and meetings
well in advance to provide the best opportunity for
a broad range of stakeholders to be able to attend.
Participatory model development phase
1. Use “translators” to facilitate the communication of
technical concepts between the content experts and
the modelling team.
2. Use intuitive and engaging activities and ensure that
these are sufficiently prepared in advance. The
activities used in these modelling case studies are
described elsewhere [34].
3. Prioritise opportunities for participants to actively
engage and interact with each other and hands-on
model development activities over less interactive
update sessions. Provide opportunities to have ful-
some discussions about priority issues.
4. Have a clear agenda and keep to time, as much as
possible, while maintaining flexibility to allow
important discussions to continue or to move on
from activities that are completed.
5. Use small group work where possible to increase
active participation.
6. Choose venues with sufficient physical space and
technical capacity.
Communication outside workshops
1. Maintain frequent communication with participants
providing progress reports, answering questions,
requesting advice and evidence.
2. Provide opportunities for direct interaction between
key participants and the modelling team to refine
the model scope and direction.
3. Identify where key issues remain for participants
and work together to try and resolve them e.g.
refining the definitions of categories or parameters
used in the model.
Using the model to inform decision making
1. Be transparent about the logic, assumptions and
parameters used in the model.
2. Use “translators” to facilitate ongoing interaction
with the model and communication of model
outputs to stakeholders.
3. Ensure that time is provided to socialise the model
with a broader stakeholder group who were not
involved in the participatory process.
4. Develop simple, clear and concise key messages
about insights from the model
5. Develop associated tools to facilitate
communication e.g. an intuitive and interactive user
interface and adaptable presentations to suit a
variety of audiences.
Limitations
Two of the three models developed in these case studies
were finalised at the time of the interviews. The partici-
pant perspectives of the utility of participatory dynamic
simulation to inform decision making was thus limited
to these two case studies. The perspectives included this
analysis were limited to participants employed by gov-
ernment agencies with jurisdiction over many of the pol-
icy and program decisions relevant to the focus topics
being modelled in these case studies. Their perspectives
may vary from those of other participants in the case
studies, for example academic researchers or representa-
tives from non-government agencies. Decision maker’s
views of different methods of dynamic simulation mod-
elling, e.g. system dynamics vs agent based modelling,
will be an important issue to explore in future research
as decision makers develop and broaden their experience
of different forms of modelling.
The lack of consumer representation in these case
studies is a limitation. The development of strategies to
realise the benefits of consumer involvement in partici-
patory dynamic simulation modelling to inform health
policy decisions is an important area for future focus.
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Conclusion
The case studies reported here have provided new in-
sights into the experience of engaging in participatory
dynamic simulation modelling from the perspectives of
the end-user policy makers and senior clinicians with
decision making roles in Australian jurisdictional health
departments. The participatory, co-production process
was viewed as an essential approach to ensure the dy-
namic simulation models incorporated the best available
knowledge and evidence for the focus issue and that the
models were well understood or “transparent” to build
trust in the model as a decision support tool for policy
discussions. The unique benefits of the dynamic simula-
tion models included being able to synthesise diverse
evidence; explore the combination and interaction of
risk factors and interventions; explore the impact of new
and untested interventions in silico; and identify evi-
dence gaps to prioritise for future research. Given the
commitment of time and resources to the participatory
model development process, it was important to ensure
that the topic justified the investment i.e. It was a high
local priority, complex and had contested options for
intervening. Engaging domain experts and people to
work as “translators” from within the stakeholder organ-
isation were important to facilitate engagement in the
process and use of the models as policy decision support
tools. Participatory modelling processes are more suit-
able for longer term planning in the first instance (prior
to the model being developed), however are responsive
to short-turnaround policy advice once developed as a
decision support tool. The ongoing refinement of model
development workshop activities and communication
tools to support the application of model findings to pol-
icy decisions will be important foci for future research
on these methods.
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